Literature DB >> 20729212

Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.

Laurent Sansregret1, David Gallo, Marianne Santaguida, Lam Leduy, Ryoko Harada, Alain Nepveu.   

Abstract

The p110 CUX1 homeodomain protein participates in the activation of DNA replication genes in part by increasing the affinity of E2F factors for the promoters of these genes. CUX1 expression is very weak in quiescent cells and increases during G(1). Biochemical activities associated with transcriptional activation by CUX1 are potentiated by post-translational modifications in late G(1), notably a proteolytic processing event that generates p110 CUX1. Constitutive expression of p110 CUX1, as observed in some transformed cells, leads to accelerated entry into the S phase. In this study, we investigated the post-translation regulation of CUX1 during mitosis and the early G(1) phases of proliferating cells. We observed a major electrophoretic mobility shift and a complete inhibition of DNA binding during mitosis. We show that cyclin B/CDK1 interacts with CUX1 and phosphorylates it at multiple sites. Serine to alanine replacement mutations at 10 SP dipeptide sites were required to restore DNA binding in mitosis. Passage into G(1) was associated with the degradation of some p110 CUX1 proteins, and the remaining proteins were gradually dephosphorylated. Indirect immunofluorescence and subfractionation assays using a phospho-specific antibody showed that most of the phosphorylated protein remained in the cytoplasm, whereas the dephosphorylated protein was preferentially located in the nucleus. Globally, our results indicate that the hyperphosphorylation of CUX1 by cyclin B/CDK1 inhibits its DNA binding activity in mitosis and interferes with its nuclear localization following cell division and formation of the nuclear membrane, whereas dephosphorylation and de novo synthesis contribute to gradually restore CUX1 expression and activity in G(1).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729212      PMCID: PMC2963374          DOI: 10.1074/jbc.M110.156406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  Multiple mechanisms regulate the proliferation-specific histone gene transcription factor HiNF-D in normal human diploid fibroblasts.

Authors:  K L Wright; R T Dell'Orco; A J van Wijnen; J L Stein; G S Stein
Journal:  Biochemistry       Date:  1992-03-17       Impact factor: 3.162

3.  Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity.

Authors:  N Segil; S B Roberts; N Heintz
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  Displacement of sequence-specific transcription factors from mitotic chromatin.

Authors:  M A Martínez-Balbás; A Dey; S K Rabindran; K Ozato; C Wu
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

5.  Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component.

Authors:  J M Gottesfeld; V J Wolf; T Dang; D J Forbes; P Hartl
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

6.  Coordination of protein-DNA interactions in the promoters of human H4, H3, and H1 histone genes during the cell cycle, tumorigenesis, and development.

Authors:  A J van Wijnen; T A Owen; J Holthuis; J B Lian; J L Stein; G S Stein
Journal:  J Cell Physiol       Date:  1991-07       Impact factor: 6.384

7.  A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.

Authors:  R P Fisher; D O Morgan
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

8.  Expression of the cut locus in the Drosophila wing margin is required for cell type specification and is regulated by a distant enhancer.

Authors:  J Jack; D Dorsett; Y Delotto; S Liu
Journal:  Development       Date:  1991-11       Impact factor: 6.868

9.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

10.  Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb.

Authors:  B Lüscher; R N Eisenman
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  6 in total

Review 1.  Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes.

Authors:  Ryan F Leung; Ankita M George; Enola M Roussel; Maree C Faux; Jeffrey T Wigle; David D Eisenstat
Journal:  Front Neurosci       Date:  2022-04-25       Impact factor: 5.152

2.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

3.  CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.

Authors:  Charles Vadnais; Sayeh Davoudi; Mojdeh Afshin; Ryoko Harada; Rachel Dudley; Pier-Luc Clermont; Elliot Drobetsky; Alain Nepveu
Journal:  Nucleic Acids Res       Date:  2012-02-08       Impact factor: 16.971

Review 4.  Stressing mitosis to death.

Authors:  Andrew Burgess; Mina Rasouli; Samuel Rogers
Journal:  Front Oncol       Date:  2014-06-04       Impact factor: 6.244

5.  Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array.

Authors:  Charles Vadnais; Arif A Awan; Ryoko Harada; Pier-Luc Clermont; Lam Leduy; Ginette Bérubé; Alain Nepveu
Journal:  BMC Genomics       Date:  2013-04-16       Impact factor: 3.969

Review 6.  CUX1, A Controversial Player in Tumor Development.

Authors:  Ning Liu; Qiliang Sun; Long Wan; Xuan Wang; Yu Feng; Judong Luo; Hailong Wu
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.